On the other hand, low GnT-V expression is associated with shorter survival and poor prognosis in non-small cell lung cancer, bladder cancer, and hepatocellular cancer (Ito et al, 2001; Dosaka-Akita et al, 2004; Ishimura et al, 2006). This evidence concerns the gene MGAT5 and urinary bladder carcinoma.